NCT06085391 is a NA clinical trial of REThink Game in Emotional Regulation, sponsored by Babes-Bolyai University.

Who is sponsoring NCT06085391?

NCT06085391 is sponsored by Babes-Bolyai University.

What drugs are being tested in NCT06085391?

Interventions in NCT06085391: REThink Game, MoodWheel, PsyPills.

What condition does NCT06085391 study?

NCT06085391 studies Emotional Regulation.

Is NCT06085391 still recruiting?

NCT06085391 is currently completed. Last updated 5 January 2024.

Last reviewed 2024-01-05 · How we verify

NCT06085391

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing the Efficacy of the REThink Emotions Platform in a Full-scale SMART Study

Completed NA Last updated 5 January 2024

What this trial tests

NA trial testing REThink Game in Emotional Regulation in 185 participants. Completed in 31 December 2023.

Timeline

7 October 2023

Primary endpoint
10 November 2023

31 December 2023

Quick facts

Lead sponsor	Babes-Bolyai University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	single
Primary purpose	prevention
Enrollment	185
Start date	7 October 2023
Primary completion	10 November 2023
Estimated completion	31 December 2023
Sites	1 location across Romania

Drugs / interventions tested

REThink Game
MoodWheel
PsyPills

Conditions studied

Emotional Regulation — all drugs for Emotional Regulation →

Sponsor

Babes-Bolyai University

Who can join

Adults 8 to 16, any sex, with Emotional Regulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This activity will have the objective of testing the validity of the integrated in-game assessment and personalized REThinkEMOTIONS platform in the prevention of emotional disorders in youth.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Validation and standardization of the Childhood Trauma Screener among Romanian children, adolescents, and college students.
David OA, Tomoiagă CT, Iuga IA. · · 2026 · PMID 41510839 · DOI 10.1002/jts.70038

Verify or expand the search:

Other trials of REThink Game

Trials testing the same drug.

NCT05257642 — Testing the Efficacy of REThink Main Game-based ER Strategies on the Stress Reactivity · NA · completed

Other recruiting trials for Emotional Regulation

Currently open trials in the same condition.

NCT06699732 — Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patient · NA · recruiting
NCT06548126 — Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families · NA · recruiting
NCT06054412 — An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers · NA · active not recruiting
NCT06236919 — E-Emotio Project A Gamified Preventive School-based Paradigm Using Virtual Reality Technologies for Improving Emotional · NA · recruiting
NCT06884020 — Emotional Regulation in School and Family: Assessment and Intervention · NA · active not recruiting

Other Babes-Bolyai University trials

Trials by the same sponsor.

NCT06646159 — REThink for Mental Health of the Youths in Romania · NA · not yet recruiting
NCT06810999 — From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms. · NA · not yet recruiting
NCT06961695 — The Efficacy of a Mindfulness-Based Virtual Reality Intervention to Reduce Pain in Postoperative Patients · NA · not yet recruiting
NCT06724666 — Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression · NA · recruiting
NCT06986928 — A Network Analysis on the Role of Specific ER Abilities as ERFs for Distress and Mental Health, in Relation to CAs Expos · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06085391 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Babes-Bolyai University
Last refreshed: 5 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06085391.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing